Puma Biotechnology, Inc. (PBYI) vs Shattuck Labs, Inc. (STTK)

Puma Biotechnology, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Puma Biotechnology, Inc. and Shattuck Labs, Inc. are of similar size ($555.0M and $543.0M). Shattuck Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs −1,230.7%). Across the 17 metrics below, Puma Biotechnology, Inc. leads on 12 and Shattuck Labs, Inc. on 5.

Valuation

Metric PBYI STTK Biotechnology median
P/E 18.20 n/m 8.50
P/S 2.17 125.47 9.71
P/B 3.61 3.33 2.13
Price to free cash flow 17.52 n/m 20.82
EV/EBITDA 10.48 n/m 0.64
EV/Sales 1.86 88.32 9.21
Earnings yield 5.49% (9.41%) (33.15%)
Free cash flow yield 5.71% (5.86%) (25.50%)

Profitability

Metric PBYI STTK Biotechnology median
Gross margin 74.83% 100.00% 65.16%
Operating margin 13.16% 0.00% 0.00%
Net margin 11.55% 0.00% 0.00%
Free cash flow margin 17.79% 0.00% 0.00%
Return on equity 21.97% (39.21%) (56.36%)
Return on assets 13.78% (36.88%) (48.04%)
Return on invested capital 42.61% (1,230.74%) 0.00%

Growth

Metric PBYI STTK Biotechnology median
Revenue growth (TTM) (2.86%) 106.48% 6.02%
EPS growth (last fiscal year) (1.61%) 53.02% 30.26%
Revenue growth, 5-year CAGR 0.29% (36.82%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBYI STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 27.59 4.72
Net debt to EBITDA (1.60) 1.62 0.96

Dividend

Metric PBYI STTK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBYI STTK Biotechnology median
Market cap 543.04m 555.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack